Cargando…
Multiple potential targets of opioids in the treatment of acute respiratory distress syndrome from COVID‐19
COVID‐19 can present with a variety of clinical features, ranging from asymptomatic or mild respiratory symptoms to fulminant acute respiratory distress syndrome (ARDS) depending on the host's immune responses and the extent of the associated pathologies. This implies that several measures need...
Autores principales: | Cismaru, Cosmin Andrei, Cismaru, Gabriel Laurentiu, Nabavi, Seyed Fazel, Ghanei, Mostafa, Burz, Claudia Cristina, Nabavi, Seyed Mohammad, Berindan Neagoe, Ioana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753383/ https://www.ncbi.nlm.nih.gov/pubmed/33211389 http://dx.doi.org/10.1111/jcmm.15927 |
Ejemplares similares
-
COVID-19 and antimalarials. Have we been doing it wrong all along?
por: Cismaru, Cosmin Andrei, et al.
Publicado: (2021) -
Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series?
por: Cismaru, Andrei Cosmin, et al.
Publicado: (2020) -
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2
por: Habtemariam, Solomon, et al.
Publicado: (2020) -
Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!
por: Habtemariam, Solomon, et al.
Publicado: (2020) -
Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
por: Dowran, Razieh, et al.
Publicado: (2020)